US Ophthalmic Pipeline and Clinical Trials

Santen is committed to developing new therapies, devices, and other solutions to serve significant unmet needs in ophthalmology and to fuel hope for physicians and patients facing the possibility of vision impairment or loss.

Our US headquarters is an important part of Santen’s global R&D development effort, allowing us to ensure the highest quality standards and an efficient process for developing differentiated ophthalmology solutions.

The following is a summary of products and devices currently in development in the United States.

RETINAL DISEASES

*This trial is not currently enrolling US patients.

GLAUCOMA

DRY EYE & CORNEAL DISORDERS


More About Our Investigational Therapies and Devices

Retinal Disorders

Glaucoma

Dry Eye & Corneal Disorders

EXPLORE OUR
FOCUS AREAS

Learn More

PARTNER
WITH US

Learn More